Tiaa Trust, National Association »

Coherus Biosciences shares owned by Tiaa Trust, National Association

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Tiaa Trust, National Association from 13F filings

Historical chart of Tiaa Trust, National Association investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Tiaa Trust, National Association consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Tiaa Trust, National Association

Quarter filed Position value Share count Share price at filing
2024-06-30 $47k 27k 1.73

More positions owned by Tiaa Trust, National Association

Ishares Core Msci Eafe Etf Exchange Traded Fund (IEFA)
Ishares Core Msci Emerging Exchange Traded Fund (IEMG)
Ishares Russell Top 200 Grow Exchange Traded Fund (IWY)
Vanguard Growth Etf Exchange Traded Fund (VUG)
Vanguard Ftse Developed Etf Exchange Traded Fund (VEA)
Vanguard Value Etf Exchange Traded Fund (VTV)
Ishares Core U.s. Aggregate Exchange Traded Fund (AGG)
Ishares Russell 1000 Growth Exchange Traded Fund (IWF)
Ishares Russell Top 200 Valu Exchange Traded Fund (IWX)
Vanguard Tax-exempt Bond Etf Exchange Traded Fund (VTEB)
Ishares Broad Usd High Yield Exchange Traded Fund (USHY)
Ishares Esg Aware Msci Usa Exchange Traded Fund (ESGU)
Ishares Russell Mid-cap Valu Exchange Traded Fund (IWS)
Ishares National Muni Bond E Exchange Traded Fund (MUB)
Ishares Msci Eafe Small-cap Exchange Traded Fund (SCZ)

View all positions for Tiaa Trust, National Association

Top funds holding Coherus Biosciences

BlackRock
BlackRock
Vanguard Group
Rubric Capital Management
Kohlberg Kravis Roberts & Co
Citadel Advisors
Geode Capital Management
Barclays
Tang Capital Management
Goldman Sachs Group
State Street Corporation
CM Management
CAM Group Holding A/S
Morgan Stanley
AQR Capital Management

View all funds holding Coherus Biosciences